The Europe IVD Market is expected to reach $39.77 billion by 2032 at a CAGR of 3.7% from 2025 to 2032. In vitro diagnostics (IVD) are tests performed on biological samples such as blood, saliva, and other tissues taken from the human body to detect a wide range ...

Europe Point-of-Care Diagnostics Market is expected to reach $12.98 billion by 2032, at a CAGR of 4.1% during the forecast period 2025–2032. Point-of-care diagnostics, or bedside tests, are diagnostic tests performed on-site by healthcare professionals. These ...

The Asia-Pacific IVD Market was valued at $21.09  billion in 2024. This market is expected to reach $36.02  billion by 2032, from an estimated $22.44  billion in 2025, at a CAGR of 7% during the forecast period 2025-2032. In vitro diagnostics (IVD) is focused ...

IVD Reagents Market Size & Forecast The IVD Reagents Market is expected to reach $79.76 billion by 2031, at a CAGR of 5.3% from 2024 to 2031. The growth of the IVD reagents market can be attributed to several factors, including the increasing prevalence of infectious ...

The Middle East IVD Market was valued at $1.57  billion in 2024. This market is expected to reach $2.15  billion by 2032, from an estimated $1.63  billion in 2025, at a CAGR of 4.1% during the forecast period 2025-2032. Middle East IVD Market Size & Forecast In ...

The Latin American IVD Market is expected to register a CAGR of 5.5% during the forecast period 2023–2030 to reach $6.45 billion by 2030. The burden of communicable and non-communicable diseases, the rise in medical tourism, the shift toward decentralized testing, ...

Point of care Diagnostics Market Size & Forecast Point of care Diagnostics Market is expected to reach $43.1 billion by 2030, at a CAGR of 5.1% from 2023–2030. The growth of this market is driven by the increasing prevalence of chronic diseases, innovations ...

The Indonesia IVD Market is expected to reach $1.11 billion by 2029, at a CAGR of 10.6% from 2022 to 2029. The growth of this market is driven by the high prevalence of infectious and chronic diseases and the growing awareness regarding the importance of early ...

The Nepal IVD Market is expected to grow at a CAGR of 12.3% from 2022 to 2029 to reach $62.7 million by 2029. The growth of the Nepal in-vitro diagnostics market is mainly attributed to the increasing prevalence of infectious & non-communicable diseases and initiatives ...

The Latin American Point-of-Care (POC) Diagnostics Market is expected to grow at a CAGR of 16.1% from 2020 to 2027 to reach at $203 million by 2027. The Latin America region has noted significant epidemiological burden of infectious diseases like severe acute respiratory ...